11/21
08:05 am
hae
Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.
Medium
Report
Haemonetics (NYSE:HAE) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $88.00 price target on the stock.
11/14
07:22 am
hae
Haemonetics (NYSE:HAE) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Low
Report
Haemonetics (NYSE:HAE) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
11/7
10:46 am
hae
Haemonetics Is Still Undervalued, Even After The Rally [Seeking Alpha]
Low
Report
Haemonetics Is Still Undervalued, Even After The Rally [Seeking Alpha]
11/7
08:20 am
hae
Haemonetics (NYSE:HAE) had its price target raised by analysts at Barrington Research from $86.00 to $90.00. They now have an "outperform" rating on the stock.
Low
Report
Haemonetics (NYSE:HAE) had its price target raised by analysts at Barrington Research from $86.00 to $90.00. They now have an "outperform" rating on the stock.
11/7
08:07 am
hae
Haemonetics (NYSE:HAE) had its price target raised by analysts at Needham & Company LLC from $68.00 to $78.00. They now have a "buy" rating on the stock.
Low
Report
Haemonetics (NYSE:HAE) had its price target raised by analysts at Needham & Company LLC from $68.00 to $78.00. They now have a "buy" rating on the stock.
11/6
02:03 pm
hae
Haemonetics (NYSE:HAE) had its price target raised by analysts at BTIG Research from $85.00 to $88.00. They now have a "buy" rating on the stock.
Low
Report
Haemonetics (NYSE:HAE) had its price target raised by analysts at BTIG Research from $85.00 to $88.00. They now have a "buy" rating on the stock.
11/6
06:17 am
hae
Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website [Yahoo! Finance]
Medium
Report
Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website [Yahoo! Finance]
11/6
06:12 am
hae
Haemonetics Non-GAAP EPS of $1.27 beats by $0.16, revenue of $327M beats by $15.51M [Seeking Alpha]
Low
Report
Haemonetics Non-GAAP EPS of $1.27 beats by $0.16, revenue of $327M beats by $15.51M [Seeking Alpha]
11/6
06:00 am
hae
Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
High
Report
Haemonetics Corporation Announces Second Quarter Fiscal 2026 Financial Results Available on Investor Relations Website
10/21
12:29 pm
hae
Haemonetics (NYSE:HAE) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $86.00 price target on the stock.
Low
Report
Haemonetics (NYSE:HAE) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $86.00 price target on the stock.
10/9
04:05 pm
hae
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2026 Results: November 6, 2025
Low
Report
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2026 Results: November 6, 2025
10/7
01:29 pm
hae
Haemonetics (NYSE:HAE) had its price target lowered by analysts at Citigroup Inc. from $78.00 to $64.00. They now have a "buy" rating on the stock.
Low
Report
Haemonetics (NYSE:HAE) had its price target lowered by analysts at Citigroup Inc. from $78.00 to $64.00. They now have a "buy" rating on the stock.
9/23
11:52 am
hae
Haemonetics (NYSE:HAE) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $86.00 price target on the stock.
Low
Report
Haemonetics (NYSE:HAE) had its "outperform" rating reaffirmed by analysts at Barrington Research. They now have a $86.00 price target on the stock.
9/18
08:05 pm
hae
Haemonetics Corporation (HAE) Launches PerQseal Elite, Advancing Minimally Invasive Vascular Care [Yahoo! Finance]
Low
Report
Haemonetics Corporation (HAE) Launches PerQseal Elite, Advancing Minimally Invasive Vascular Care [Yahoo! Finance]